When it comes to peripheral intravenous (IV) therapy, doctors and nurses have come to accept that things might not go smoothly. Nearly 80% of hospital patients in the U.S. receive an IV — a procedure ...

NEWPORT NEWS, Va., March 10, 2026 /PRNewswire/ -- ivWatch, the IV safety company, has partnered with Aon, a leading global insurance broker and risk consultant, to quantify the clinical and financial ...

NEWPORT NEWS, Va., April 8, 2024 /PRNewswire/ -- A new study published in the peer-reviewed British Journal of Nursing this month examines several important metrics that describe the performance of ...

NEWPORT NEWS, Va., July 7, 2020 /PRNewswire/ -- ivWatch, LLC, a pioneer in biosensor technology, has received FDA clearance for its new SmartTouch TM disposable sensor for the early detection of ...

Intravenous administration of fluids and medication is incredibly common among hospital patients. But the failure rate of IVs is relatively high--estimated at more than 20%. These issues can result in ...

We evaluated prospectively the effect of 11 variables on the survival of PVL. PVL were monitored from the time of cannula placement to discontinuation. Sites were inspected hourly for clinical signs ...

Check the infusion pump's occlusion alarm limit setting. The alarm should be set at the lowest available limit to prevent false occlusion alarms while detecting infiltration. Evaluate the pump's ...

ivWatch announced the FDA's clearance of its namesake product to continuously monitor peripheral IVs for adverse events like infiltration of IV fluids into the surrounding skin and the leakage of ...

HAMPTON, Va.--(BUSINESS WIRE)--ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, recently had two patent ...

The necessity for routine replacement of an IV peripheral cannula to prevent bacteremia was evaluated in a high-quality randomized trial. Patients older than 18 years (N = 755) without current ...